Most Read Articles
02 Jul 2018
The use of beta-blockers in patients with heart failure with preserved ejection fraction (HFpEF), especially in those without histories of myocardial infarction, appears to increase the risk of adverse cardiovascular events, according to a recent study.
Stephen Padilla, 09 Jul 2018
Compared with warfarin, apixaban appears to be the safest drug among direct oral anticoagulants (DOACs), with decreased risks of major, intracranial and gastrointestinal bleeding, suggests a study. However, low-dose apixaban and rivaroxaban are associated with increased risks of all-cause mortality compared with warfarin.
24 Jun 2018
Sleep problems and depressive symptoms, and a combination of both, are differentially associated with the future incidence of physical illness, according to a study.
05 Jul 2018
Different measures of fitness and physical activity appear to be inversely associated with the risk of developing cardiovascular disease in the general population, as well as in individuals with elevated genetic risk for these diseases, according to a study.

Advanced pulmonary vasodilators linked to greater survival in Eisenmenger syndrome

09 Sep 2017

Treatment with advanced pulmonary vasodilator therapy (AT) appears to confer survival benefits in patients with Eisenmenger syndrome (ES) whose illness severity may be greater prior to treatment, according to a study.

Researchers followed 253 adult ES patients (mean age 31 years; 60 percent female) from 12 adult congenital heart disease centres across Australia and New Zealand. Demographic, medical and outcome data were collected and analysed prospectively and retrospectively.

At diagnosis of ES, 64 percent had World Health Organization (WHO) functional class ≥3. Ventricular septal defect was the most common underlying lesion, identified in 33 percent of patients, including 21 percent with “complex” anatomy.

During a median follow-up of 9.1 years, majority of patients (72 percent) were prescribed at least one AT (49 percent single agent), with bosentan mostly (66 percent; n=168). The mean time on AT was 6 years.

Compared with nonexposed patients, those with AT exposure were more functionally impaired at presentation (WHO ≥3, 69 vs 51 percent; p=0.007) and more likely to have been prescribed anticoagulation (47 vs 27 percent; p=0.003). The risk of death/transplant per year was 4.8 percent in the AT-exposed group vs 8.4 percent in the never-exposed group.

Multivariable Cox proportional hazards analysis found AT exposure to be independently associated with greater survival (hazard ratio [HR] for survival, 2.27; 95 percent CI, 1.49 to 3.45; p<0.001), whereas WHO ≥3 at presentation was associated with a worse prognosis (HR for mortality, 1.82; 1.19 to 2.78; p=0.006).

“ES occurs in patients with a structurally abnormal heart where intracardiac or extracardiac systemic to pulmonary communications result in severe pulmonary vascular disease thence right to left shunting, leading to chronic cyanosis,” researchers said.

“The finding of greater long-term survival in those treated with AT as compared with those untreated may be instructive for both therapeutic algorithms in [patients] with ES and in the design of future randomized trials to confirm this association,” they added.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
02 Jul 2018
The use of beta-blockers in patients with heart failure with preserved ejection fraction (HFpEF), especially in those without histories of myocardial infarction, appears to increase the risk of adverse cardiovascular events, according to a recent study.
Stephen Padilla, 09 Jul 2018
Compared with warfarin, apixaban appears to be the safest drug among direct oral anticoagulants (DOACs), with decreased risks of major, intracranial and gastrointestinal bleeding, suggests a study. However, low-dose apixaban and rivaroxaban are associated with increased risks of all-cause mortality compared with warfarin.
24 Jun 2018
Sleep problems and depressive symptoms, and a combination of both, are differentially associated with the future incidence of physical illness, according to a study.
05 Jul 2018
Different measures of fitness and physical activity appear to be inversely associated with the risk of developing cardiovascular disease in the general population, as well as in individuals with elevated genetic risk for these diseases, according to a study.